Sequential QoQ Revenue Growth of 10.4%, Adjusted EBITDA Growth of 52% Trailing Twelve Months Revenue Growth of 13%, Adjusted EBITDA Growth of 116% MISSISSAUGA, Ontario / Aug 21, 2025 / Business Wire / Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2025 third quarter results for the period ended June 30, 2025, along with a... Read More